These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 8844209)

  • 81. Heterozygosity for Tay-Sachs disease in non-Jewish Americans with ancestry from Ireland or Great Britain.
    van Bael M; Natowicz MR; Tomczak J; Grebner EE; Prence EM
    J Med Genet; 1996 Oct; 33(10):829-32. PubMed ID: 8933335
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Collaborative study of the molecular epidemiology of Tay-Sachs disease in Europe.
    Akli S; Boue J; Sandhoff K; Kleijer W; Vamos E; Young E; Gatti R; Di Natale P; Motte J; Vanier MT
    Eur J Hum Genet; 1993; 1(3):229-38. PubMed ID: 8044648
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Novel mutations, including the second most common in Japan, in the beta-hexosaminidase alpha subunit gene, and a simple screening of Japanese patients with Tay-Sachs disease.
    Tanaka A; Fujimaru M; Choeh K; Isshiki G
    J Hum Genet; 1999; 44(2):91-5. PubMed ID: 10083731
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
    Navon R; Adam A
    Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
    [No Abstract]   [Full Text] [Related]  

  • 85. Carrier screening panels for Ashkenazi Jews: is more better?
    Leib JR; Gollust SE; Hull SC; Wilfond BS
    Genet Med; 2005 Mar; 7(3):185-90. PubMed ID: 15775754
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A genetic screening programme for Tay-Sachs disease and cystic fibrosis for Australian Jewish high school students.
    Barlow-Stewart K; Burnett L; Proos A; Howell V; Huq F; Lazarus R; Aizenberg H
    J Med Genet; 2003 Apr; 40(4):e45. PubMed ID: 12676918
    [No Abstract]   [Full Text] [Related]  

  • 87. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
    Landels EC; Ellis IH; Bobrow M; Fensom AH
    J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Molecular and clinical heterogeneity of adult GM2 gangliosidosis.
    Navon R
    Dev Neurosci; 1991; 13(4-5):295-8. PubMed ID: 1840100
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P; Boulay B; Bayleran J; Andermann E
    Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Strategies to respond to polymerase chain reaction deoxyribonucleic acid amplification failure in a preimplantation genetic diagnosis program.
    Gibbons WE; Gitlin SA; Lanzendorf SE
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1088-95; discussion 1095-6. PubMed ID: 7726246
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A Pst+ polymorphism in the HEXA gene with an unusual geographic distribution.
    Kaplan F; Kapoor S; Lee D; Fernandes M; Vienozinskis M; Mascisch A; Scriver CR; Lim-Steele J; Kaback M; Zeiger K; Zoossman-Diskin A; Bonne-Tamir B; Landels E; Bobrow M; Hechtman P
    Eur J Hum Genet; 1993; 1(4):301-5. PubMed ID: 8081943
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
    Sutton VR
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Biallelic discrimination assays for the three common Ashkenazi Jewish mutations and a common non-Jewish mutation, in Tay-Sachs disease, using fluorogenic TaqMan probes.
    Ward CP; Fensom AH; Green PM
    Genet Test; 2000; 4(4):351-8. PubMed ID: 11216658
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect.
    Navon R; Kolodny EH; Mitsumoto H; Thomas GH; Proia RL
    Am J Hum Genet; 1990 Apr; 46(4):817-21. PubMed ID: 2278539
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Polymerase chain reaction-generated heteroduplexes from Ashkenazi Tay-Sachs carriers with an insertion mutation can be detected on agarose gels.
    Shore S; Myerowitz R
    Am J Hum Genet; 1990 Jul; 47(1):169. PubMed ID: 2349947
    [No Abstract]   [Full Text] [Related]  

  • 96. Cystic fibrosis in Jews: frequency and mutation distribution.
    Kerem B; Chiba-Falek O; Kerem E
    Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
    Guetta E; Peleg L
    Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Six novel deleterious and three neutral mutations in the gene encoding the alpha-subunit of hexosaminidase A in non-Jewish individuals.
    Mules EH; Hayflick S; Miller CS; Reynolds LW; Thomas GH
    Am J Hum Genet; 1992 Apr; 50(4):834-41. PubMed ID: 1532289
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Distribution of a pseudodeficiency allele among Tay-Sachs carriers.
    Tomczak J; Boogen C; Grebner EE
    Am J Hum Genet; 1993 Aug; 53(2):537-9. PubMed ID: 8328470
    [No Abstract]   [Full Text] [Related]  

  • 100. Assessing the potential success of cystic fibrosis carrier screening: lessons learned from Tay-Sachs disease and beta-thalassemia.
    Laberge AM; Watts C; Porter K; Burke W
    Public Health Genomics; 2010; 13(5):310-9. PubMed ID: 19864874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.